Skip to main content
. 2021 Aug;9(15):1229. doi: 10.21037/atm-21-1883

Figure 3.

Figure 3

Safety profile (A) and ranking histograms (B) according to the drug based network meta-analysis in the consistency model. Each cell of the safety profile contains the pooled odds ratios and 95% confidence intervals for grade 3–5 adverse events; significant results are in bold. Ranking histograms indicate the probability of the highest risk of grade 3–5 adverse events, the second highest, the third highest, and so on. PARPi, poly (ADP-ribose) polymerase inhibitor; AI, angiogenesis inhibitor.